With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Dissecting Functional uORFs as a Source of Cancer Genes in High-Risk Medulloblastoma||Dana-Farber Cancer Institute / John Prensner, MD/PhD||Young Investigator Grants||2021||Massachusetts|
|Characterizing Inflammatory Phenotypes Associated with RUNX1 Deficiency||Dana-Farber Cancer Institute / Waihay Wong, MD/PhD||RUNX1 Early Career Investigator Grants||2021||Massachusetts|
|Dual PTK7/GD2 Gamma Delta CAR T Cell Therapy for Neuroblastoma||Emory University / Kelly Goldsmith, MD & H. Trent Spencer, PhD & Chris B. Doering, PhD||Reach Grants||2021||Georgia|
|The Role of LIN28B-let-7-PBK Axis on the Growth and Metastasis of Group 3 Medulloblastoma||Emory University / Shubin Shahab, MD/PhD||Young Investigator Grants||2021||Georgia|
|Phosphopeptides as shared targets for donor derived T cell therapy of AML||Memorial Sloan-Kettering Cancer Center / Richard O'Reilly, MD||Innovation Grants||2021||New York|
|Unraveling metabolic dependencies in childhood supratentorial ependymomas.||Regents of the University of Michigan / Sriram Venneti, MD/PhD||Innovation Grants||2021||Michigan|
|Investigating Epigenetic Mechanisms of Response to Allogenic CAR T Cell Therapy||St. Jude Children's Research Hospital / Caitlin Zebley, MD/PhD||Young Investigator Grants||2021||Tennessee|
|Hematopoietic Stem And Progenitor Cells Sustain Inflammation And Promote Relapse In The AML Niche||Children's Hospital of Philadelphia / Ding-Wen (Roger) Chen, PhD||Young Investigator Grants||2021||Pennsylvania|
|Loss of ER-mitochondria contacts drives therapy resistance in neuroblastoma||Children's Hospital of Philadelphia / Michael Hogarty, MD||Innovation Grants||2021||Pennsylvania|
|Social Determinants of Health, Hospital-level Resources, and Risk of Septic Shock in Pediatric Leukemia||Children's Hospital of Philadelphia / Jenny Ruiz, MD||Young Investigator Grants||2021||Pennsylvania|